Research Article
[Retracted] KDOAM-25 Overcomes Resistance to MEK Inhibitors by Targeting KDM5B in Uveal Melanoma
Figure 3
KDOAM-25 inhibits the expression of KDM5B in UM. (a) Western blot analysis of the H3K4me3 and H3K27ac in OMM1-P and OMM1-R cells treated with indicated concentrations of Tra for 24 h. (b) Quantitative analysis of H3K4me3 and H3K27ac ratio to β-actin. (c) Western blot analysis of the KDM5B in OMM1-P and OMM1-R cells treated with Tra (5 μM) for 24 h. (d) Quantitative analysis of KDM5B ratio to β-actin. (e) Western blot analysis of KDM5B knockdown efficiency in OMM1-R cells. (f) Quantitative analysis of KDM5B ratio to β-actin. (g) The CCK8 assay of cell viability in OMM1-R cells which knockdown of KDM5B. ; two-way ANOVA in (b, d, g); one-way ANOVA in (f).
| (a) |
| (b) |
| (c) |
| (d) |
| (e) |
| (f) |
| (g) |